Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
about
Are statins diabetogenic?Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammationiNKT and MAIT Cell Alterations in DiabetesThe central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetesConsiderations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 DiabetesNatural history of β-cell adaptation and failure in type 2 diabetesMinireview: Emerging Concepts in Islet Macrophage Biology in Type 2 DiabetesCNC-bZIP protein Nrf1-dependent regulation of glucose-stimulated insulin secretionGlucose kinetics in the collagen-induced arthritis model: an all-in-one model to assess both efficacy and metabolic side effects of glucocorticoidsHepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathwayA genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans.Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes.A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus.Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function.The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation.Possible protective effect of membrane lipid rafts against interleukin-1β-mediated anti-proliferative effect in INS-1 cells.Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cellsProtein kinase C delta (PKCδ) affects proliferation of insulin-secreting cells by promoting nuclear extrusion of the cell cycle inhibitor p21Cip1/WAF1.Transcription of the gene encoding TNF-α is increased by IL-1β in rat and human islets and β-cell linesAn overview of the identification and management of the metabolic syndrome in chiropractic practice.NR4A1 is associated with chronic low-grade inflammation in patients with type 2 diabetes.Low high-density lipoprotein cholesterol level is a significant risk factor for development of type 2 diabetes: Data from the Hawaii-Los Angeles-Hiroshima study.CREB mediates the insulinotropic and anti-apoptotic effects of GLP-1 signaling in adult mouse β-cells.Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation.Impact of islet autoimmunity on the progressive β-cell functional decline in type 2 diabetes.Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats.Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.β-Cell inflammation in human type 2 diabetes and the role of autophagy.Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty ratsAdministration of heme arginate ameliorates murine type 2 diabetes independently of heme oxygenase activity.Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats.Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats.Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans.Hypothyroidism Affects Vascularization and Promotes Immune Cells Infiltration into Pancreatic Islets of Female Rabbits.Angiotensin converting enzyme 2: a new important player in the regulation of glycemia.Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD miceEffects of gevokizumab on glycemia and inflammatory markers in type 2 diabetesAutoantibodies against β1-adrenoceptor induce blood glucose enhancement and insulin insufficient via T lymphocytesHow biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes.
P2860
Q24630205-F010EAAF-6441-4ED5-86A4-2A1394716300Q26766681-0B1FE2AD-F214-4B39-A39D-31EC7F5A2D4BQ26801962-DAE033B9-F0CD-472B-A73E-D3740CFCBCDAQ26860579-43CE3D6C-5818-48D1-9224-B956695C76D1Q28073309-035531AB-1C7F-4687-8CFD-7E44557C3762Q28082002-7DEA7510-158E-4FCC-AFE9-4394370152A7Q28083768-AD5CD4EE-27FA-45F6-B21B-76F7ED58AC91Q28254868-C2E393F1-7E73-4BDE-9C34-DD68506D69F7Q28542681-9113CB0B-E406-4F19-A1FF-930B016CBEC7Q28728915-13A8B650-D2A2-4B83-959F-0FB0073132A4Q29417144-4E65447C-2170-4598-9BB1-6ACEB49125AAQ30428421-D9940CF7-5A49-4AD5-8FEF-F8CB2DFE96A9Q33607642-56BABC56-5991-4C49-B855-037A3600088AQ33746422-57C2223E-1E95-4F34-8401-6551B4E69923Q33850372-C39F96D8-878A-4D35-BC95-92DCBF0A173FQ33854517-484B28D1-B625-4960-A218-71969ACADD61Q33960501-EE17DE35-3FCB-4368-88B6-514E68941910Q34106145-9B6BB863-D23A-4EEA-9360-3807C7AE8945Q34116998-80E1D9E7-95BF-427B-ADAF-A9758BD83300Q34146626-EAEDD4BD-27F3-478E-99FC-B862186F92E2Q34168107-0778D7CB-C6DB-4357-8274-F7C1A3D1B96FQ34292205-2F19EFAA-61EA-46C0-9A81-69634A62371EQ34299607-9F8DAD2E-3389-4350-8A2E-88C09E48F322Q34436650-BA761BE0-D7FE-442F-B9F2-F306DBCCD16CQ34461002-DF65C817-2EB3-4C6C-8A03-9F3067C0E5EAQ34545320-4D9A3E28-679A-4400-84F6-DF36B60DE611Q34586474-3505DF06-708D-409B-B5B3-D6678FE11D63Q34597496-D4E9CD4D-F23B-41EB-8FC4-B37CAEC9C9BDQ34977998-5B07AF70-36EB-4C91-BADD-D8BAFFF5BC86Q35006077-84B7A17D-47F4-4AC6-833B-A7486C6140CFQ35036210-6FB0B553-5268-4438-B75E-4B6A214681AFQ35430781-53C534B8-4D2A-4EED-A452-A994D6FE5471Q35579519-89A69E44-D59A-4205-93F8-62BA573D935AQ35696531-55DD76B4-CB97-4D3E-A4F3-6E7797FE187EQ35794131-4148281D-0026-4A56-85CC-F2FB1442DEC5Q36020040-54909F09-1CF2-497C-8739-84EBF0A254C2Q36047577-1BB527E7-8EF8-4155-8BBC-B86DB6AFABBBQ36109128-5639E859-6859-4401-A159-89FA81BAF4BAQ36678532-D1E9EB4F-3EE4-40BC-966F-E24A92AA0C9AQ37064752-F0C94986-DFA8-4346-8834-7533FCDEA64B
P2860
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
@en
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
@nl
type
label
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
@en
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
@nl
prefLabel
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
@en
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
@nl
P2093
P1433
P1476
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes
@en
P2093
Helga Ellingsgaard
Marc Y Donath
Marianne Böni-Schnetzler
P304
P356
10.1152/PHYSIOL.00032.2009
P50
P577
2009-12-01T00:00:00Z